These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26117435)

  • 21. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD).
    Stankevich Y; Lueken U; Balzer-Geldsetzer M; Dodel R; Gräber-Sultan S; Berg D; Liepelt-Scarfone I; Hilker-Roggendorf R; Kalbe E; Kaut O; Mollenhauer B; Reetz K; Schäffer E; Schmidt N; Schulz JB; Spottke A; Witt K; Linse K; Storch A; Riedel O
    Am J Geriatr Psychiatry; 2018 Oct; 26(10):1079-1090. PubMed ID: 30082208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apathy in elderly nondemented patients with Parkinson's disease: clinical determinants and relationship to quality of life.
    Skorvanek M; Rosenberger J; Gdovinova Z; Nagyova I; Saeedian RG; Groothoff JW; Dijk JP
    J Geriatr Psychiatry Neurol; 2013 Dec; 26(4):237-43. PubMed ID: 23970460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease.
    Lueken U; Evens R; Balzer-Geldsetzer M; Baudrexel S; Dodel R; Gräber-Sultan S; Hilker-Roggendorf R; Kalbe E; Kaut O; Mollenhauer B; Reetz K; Schäffer E; Schmidt N; Schulz JB; Spottke A; Witt K; Linse K; Storch A; Riedel O
    Int J Methods Psychiatr Res; 2017 Dec; 26(4):. PubMed ID: 28418163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study.
    Santangelo G; Vitale C; Trojano L; Picillo M; Moccia M; Pisano G; Pezzella D; Cuoco S; Erro R; Longo K; Pellecchia MT; Amboni M; De Rosa A; De Michele G; Barone P
    Eur J Neurol; 2015 Feb; 22(2):253-60. PubMed ID: 24848193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of apathy in treatment-naïve patients with Parkinson's disease.
    Terashi H; Ueta Y; Kato H; Mitoma H; Aizawa H
    Int J Neurosci; 2019 Jan; 129(1):16-21. PubMed ID: 30035696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia.
    Lee WJ; Tsai CF; Gauthier S; Wang SJ; Fuh JL
    Int Psychogeriatr; 2012 Dec; 24(12):1980-7. PubMed ID: 22835209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of demotivation and affective disorders in apathy in patients with Parkinson's disease without dementia and depression].
    Delgadillo-Iniguez D; Derouesné C; Lacomblez L; Gély-Nargeot MC
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):197-207. PubMed ID: 23803637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline predictors of worsening apathy in Parkinson's disease: A prospective longitudinal study.
    Wee N; Kandiah N; Acharyya S; Chander RJ; Ng A; Au WL; Tan LC
    Parkinsonism Relat Disord; 2016 Feb; 23():95-8. PubMed ID: 26705846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis.
    Cochrane GD; Rizvi S; Abrantes AM; Crabtree B; Cahill J; Friedman JH
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1093-5. PubMed ID: 26228083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimensions of apathy in Parkinson's disease: exploratory factor analysis of the apathy scale.
    Kay DB; Kirsch-Darrow L; Zahodne LB; Okun MS; Bowers D
    J Parkinsons Dis; 2012; 2(2):161-6. PubMed ID: 23939440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apathy and depression in Parkinson's disease: the Belgrade PD study report.
    Ziropadja Lj; Stefanova E; Petrovic M; Stojkovic T; Kostic VS
    Parkinsonism Relat Disord; 2012 May; 18(4):339-42. PubMed ID: 22166396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apathy is associated with activities of daily living ability in Parkinson's disease.
    Laatu S; Karrasch M; Martikainen K; Marttila R
    Dement Geriatr Cogn Disord; 2013; 35(5-6):249-55. PubMed ID: 23485683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers.
    Olde Dubbelink KT; Hillebrand A; Twisk JW; Deijen JB; Stoffers D; Schmand BA; Stam CJ; Berendse HW
    Neurology; 2014 Jan; 82(3):263-70. PubMed ID: 24353335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonmotor Symptoms and Cognitive Decline in de novo Parkinson's Disease.
    Kwon KY; Kang SH; Kim M; Lee HM; Jang JW; Kim JY; Lee SM; Koh SB
    Can J Neurol Sci; 2014 Sep; 41(5):597-602. PubMed ID: 25373810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study.
    Siciliano M; Trojano L; De Micco R; Giordano A; Russo A; Tedeschi G; Chiorri C; Tessitore A
    Parkinsonism Relat Disord; 2020 Oct; 79():3-8. PubMed ID: 32853825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson's disease.
    Varanese S; Perfetti B; Ghilardi MF; Di Rocco A
    PLoS One; 2011 Mar; 6(3):e17846. PubMed ID: 21437255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.